Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Discover effective ways to increase your savings rate, helping you reach your financial goals faster.
22,326 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Trump abruptly delays signing the 21st Century ROAD to Housing Act, tying its fate to passage of the SAVE AMERICA ACT...
Bitcoin has slid to around 60K in six weeks, wiping out years of gains. This piece examines this hidden reason behind...
In a choppy market, one defense contractor shines as a rare dividend stock built for downturns. Its government-backed...
Micron Technology stunned investors with an earnings beat and an ultra-high gross margin, suggesting it is riding an ...
Bitcoin hovers around $60,000 as weekend trading begins, with a pivotal options expiry and inflation data in focus. A...
Strategy’s perpetual preferred stock has fallen from the $100 issuance price to the mid-$70s, prompting widespread in...
Taylor Morrison’s proxy shows a patient, staged sale to Berkshire Hathaway, highlighting a cautious appetite for big-...
NVIDIA has surged to the top of many investors' lists as AI demand accelerates. This highest-conviction stock right n...
Stryker and Intuitive Surgical reported divergent Q1 2026 results, underscoring two distinct medtech playbooks. Stryk...
The White House signals a pivot from extending USMCA to pursuing bilateral agreements with Canada and Mexico, with a ...
As 2026 unfolds, investors debate whether ripple worth holding through the year hinges on regulatory clarity, adoptio...